ImmunityBio, Inc. (IBRX) Stock price, Description, News & Info

#ThinkSabio Latest News

ImmunityBio Receives FDA Expanded Access Authorization for Landmark Treatment of Lymphopenia With ANKTIVA®, the Cancer BioShield™ Platform, in Patients With Solid Tumors